{"Q": 1, "answer": "no", "rationale": "The segment describes testing plans, but does not use an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19072", "batch_size": 200, "batch_pos": 82, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral verbs like 'said' and 'begin' without high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_12384", "batch_size": 200, "batch_pos": 19, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The verb 'would begin' is future tense, not describing realised impact.", "method": "llm_batch", "batch_id": "batch_3_18536", "batch_size": 200, "batch_pos": 169, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17468", "batch_size": 200, "batch_pos": 158, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports the timeline for testing without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16504", "batch_size": 200, "batch_pos": 155, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_4856", "batch_size": 200, "batch_pos": 112, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_12552", "batch_size": 200, "batch_pos": 97, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a future action/timeline for capability development ('late-stage testing would begin') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_16024", "batch_size": 200, "batch_pos": 76, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
